D. Wagner

发表

Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling

D. Harrison, E. Nozik-Grayck, J. Fessel, 2013, Pulmonary circulation.

The specific antigen approach in multiple sclerosis: can it ever be enough?

D. Wagner, 2012, Clinical immunology.

Role of the CD40‐CD40 ligand interaction in CD4+ T cell contact‐dependent activation of monocyte interleukin‐1 synthesis

J. Suttles, R. Stout, D. Wagner, 1994, European journal of immunology.

Role of the Cd40-cd40 Ligand Interaction in Cd4(+) T Cell Activation of Monocyte Interleukin-1 Synthesis

D. Wagner, 1994 .

A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis

D. Wagner, G. Vaitaitis, Martin G. Yussman, 2019, Journal of Neuroimmunology.

A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice

Michael H. Olmstead, D. Wagner, G. Vaitaitis, 2014, Diabetologia.

Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis

D. Wagner, 2017, Front. Endocrinol..

An analytical workflow for investigating cytokine profiles

H. Maecker, M. Inokuma, J. Siebert, 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Mediated by C D 2 8 / C T L A-4 Cos t imula tory Interact ions wi th B 7-1 / B 7-2 By

P. Linsley, M. Newell, J. Hagman, 2002 .

Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2

P. Linsley, J. Freed, M. Newell, 1996, The Journal of experimental medicine.

Galectin-9 Controls CD40 Signaling through a Tim-3 Independent Mechanism and Redirects the Cytokine Profile of Pathogenic T Cells in Autoimmunity

D. Wagner, G. Vaitaitis, 2012, PloS one.

CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

D. Wagner, G. Vaitaitis, 2010, Molecular immunology.

Challenges to Reshape the Future of Type 1 Diabetes Research.

D. Bleich, D. Wagner, 2018, The Journal of clinical endocrinology and metabolism.

Peripheral CD4loCD40+ auto‐aggressive T cell expansion during insulin‐dependent diabetes mellitus

D. Wagner, G. Vaitaitis, D. Waid, 2004, European journal of immunology.

expansion during insulin-dependent diabetes mellitus

D. Wagner, G. Vaitaitis, D. Waid, 2004 .

Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes

D. Wagner, N. Pennock, G. Vaitaitis, 2008, Journal of leukocyte biology.

CD40 engagement of CD4+CD40+ T cells in a neo‐self antigen disease model ablates CTLA‐4 expression and indirectly impacts tolerance

D. Wagner, G. Vaitaitis, D. Waid, 2012, European journal of immunology.

High Distribution of CD40 and TRAF2 in Th40 T Cell Rafts Leads to Preferential Survival of this Auto-Aggressive Population in Autoimmunity

D. Wagner, G. Vaitaitis, 2008, PloS one.

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor.

P. Gottlieb, M. Rihanek, A. Alkanani, 2019, The Journal of clinical endocrinology and metabolism.

The Pathology of Bleomycin‐Induced Fibrosis Is Associated with Loss of Resident Lung Mesenchymal Stem Cells That Regulate Effector T‐cell Proliferation

E. Nozik-Grayck, M. Rojas, D. Klemm, 2011, Stem cells.

γδ+ T Cells Regulate Major Histocompatibility Complex Class II (IA and IE)-Dependent Susceptibility to Coxsackievirus B3-Induced Autoimmune Myocarditis

M. Newell, S. Huber, C. David, 1999, Journal of Virology.

Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad.

D. Wagner, 2007, Clinical immunology.

CD40‐mediated signalling influences trafficking, T‐cell receptor expression, and T‐cell pathogenesis, in the NOD model of type 1 diabetes

D. Wagner, G. Vaitaitis, Martin G. Yussman, 2017, Immunology.

Abnormal protein translocation as the elusive cause of cystic fibrosis: an hypothesis.

D. Wagner, J. Herd, I. LeClair, 1990, Medical hypotheses.

A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.

P. Gottlieb, A. Putnam, D. Wagner, 2007, Clinical immunology.

Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes

K. Haskins, D. Wagner, M. Poulin, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Isolation & Characterization of Hoechstlow CD45negative Mouse Lung Mesenchymal Stem Cells

S. Majka, Kelsey S. Chow, D. Wagner, 2011, Journal of visualized experiments : JoVE.

Peripheral CD 4 loCD 40 + auto-aggressive T cell expansion during insulin-dependent diabetes mellitus

D. Wagner, G. Vaitaitis, D. Waid, 2004 .

Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells

D. Wagner, G. Vaitaitis, Martin G. Yussman, 2017, PloS one.

Th 40 cells ( CD 4 + CD 40 + Tcells ) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD 4 T cells

D. Wagner, G. Vaitaitis, Martin G. Yussman, 2017 .

T Cell Regulator Controlled through CD40 An Alternative Role for Foxp3 As an Effector

Michael H. Olmstead, D. Wagner, G. Vaitaitis, 2013 .

IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis.

J. Suttles, R. Miller, R. Stout, 1997, Journal of immunology.

The co-evolution of our understanding of CD40 and inflammation

D. Wagner, 2009, Diabetologia.

Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS)

D. Wagner, G. Vaitaitis, D. Waid, 2022, Journal of Neuroimmunology.

Are we aiming to miss in translational autoimmunity treatments?

D. Wagner, G. Vaitaitis, 2018, F1000Research.

Are we aiming to miss in translational autoimmunity treatments?

D. Wagner, G. Vaitaitis, 2018, F1000Research.

CD40 Drives Central Nervous System Autoimmune Disease by Inducing Complementary Effector Programs via B Cells and Dendritic Cells.

R. Hodes, D. McGavern, Cayce E. Dorrier, 2022, Journal of immunology.

Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells

T. Schreiner, J. Corboy, D. Wagner, 2014, Journal of Neuroimmunology.

CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression

D. Wagner, G. Vaitaitis, 2013, Cellular and Molecular Immunology.

Cutting Edge: CD40-Induced Expression of Recombination Activating Gene (RAG) 1 and RAG2: A Mechanism for the Generation of Autoaggressive T Cells in the Periphery1

K. Haskins, D. Wagner, M. Poulin, 2003, The Journal of Immunology.

A unique Tcell subset described as CD4 lo CD40 + Tcells (T CD40 ) in human type 1 diabetes

P. Gottlieb, A. Putnam, D. Wagner, 2007 .

The Role of T Cells in Type 1 Diabetes

D. Wagner, 2011 .

Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?)

D. Wagner, 2016, Clinical and experimental immunology.

CD40 on NOD CD4 T cells contributes to their activation and pathogenicity.

K. Haskins, R. Baker, D. Wagner, 2008, Journal of autoimmunity.

Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitation

R. Traystman, P. Herson, D. Wagner, 2014, Journal of Neuroimmunology.

Modulating CD40 and integrin signaling in the proinflammatory nexus using a 15-amino-acid peptide, KGYY15

D. Wagner, G. Vaitaitis, 2023, The Journal of biological chemistry.

CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter]

Michael H. Olmstead, D. Wagner, G. Vaitaitis, 2019, Diabetologia.

The Expanding Role of TNF-Receptor Super Family Member CD40 (tnfrsf5) in Autoimmune Disease: Focus on Th40 Cells

D. Wagner, G. Vaitaitis, D. Waid, 2010 .

An Alternative Role for Foxp3 As an Effector T Cell Regulator Controlled through CD40

Michael H. Olmstead, D. Wagner, G. Vaitaitis, 2013, The Journal of Immunology.

Importance of CD40/CD40 dyad in the course of infection with Trypanosoma cruzi: Impact of its inhibition.

F. Frank, D. Wagner, M. Postan, 2023, Microbial pathogenesis.

Increased expression of CD40 on thymocytes and peripheral T cells in autoimmunity: a mechanism for acquiring changes in the peripheral T cell receptor repertoire.

J. Freed, E. Newell, M. Newell, 1999, International journal of molecular medicine.

Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes

D. Wagner, N. Pennock, G. Vaitaitis, 2008, Journal of leukocyte biology.